Senores Pharmaceuticals Limited has informed the Exchange about Link of Recording
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges that the audio recording of its earnings conference call for the quarter ended June 30, 2025 (Q1 FY26) is now available on the company's website. The call was held on July 24, 2025 and was attended by Chairman Sanjay Majmudar, Managing Director Swapnil Shah, and CFO Deval Shah, along with several analysts, institutional investors, and funds. The filing is being made in compliance with SEBI LODR Regulations 30 and 46, and the company has stated that no unpublished price sensitive information was shared during the call.
This is a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price. Investors who want to listen to management's commentary on Q1 FY26 results can access the recording via the company's investor page.